Whitney Coultas
Nurse Practitioner · Medford, ORNPI 1053088575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $758 of the $848 with a category attached, or 89.4%. It is spread thinly across 15 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$154
- Exact Sciences$146
- Astellas Pharma US Inc$126
- AbbVie$95
- Organon$56
- Daiichi Sankyo Inc.$38
- plus $233 from 9 others
What the payments were for
- Food & beverage$75889%
- Education$9011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $154 |
| Exact Sciences | 6 | $146 |
| Astellas Pharma US Inc | 3 | $126 |
| AbbVie | 4 | $95 |
| Organon | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Amgen | 2 | $38 |
| Coopersurgical, Inc. | 2 | $37 |
| Blueprint Medicines Corporation | 1 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Sanofi | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$848 in reported general payments places this provider in the 90th percentile of 997 nurse practitioner providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 34 | $1,963 |
| Levothyroxine Sodium | 58 | $1,039 |
| Estradiol | 27 | $776 |
| Lisinopril | 22 | $145 |
| Gabapentin | 11 | $144 |
| Losartan Potassium | 14 | $144 |
| Amlodipine Besylate | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Medford
- Maria RiveraMedford$2K
- Johnny PayneMedford$2K
- Jared ThomasMedford$2K
- Cynthia MosserMedford$2K
- Nicolette CortezMedford$1K
- Heather MataMedford$862
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Alana WilsonPortland$58K
- Jennifer MurdochPortland$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.